Explore News By Topic


The Prostate Cancer Foundation and the American Cancer Society Announce First ACS-PCF Young Investigator Award

LOS ANGELES, Calif., February 22, 2024 – The Prostate Cancer Foundation (PCF) and the American Cancer Society (ACS) today announced the ACS-PCF Young Investigator Award totaling $225,000 over three years to support a novel health equity research project that aims to reduce disparities in access to modern prostate cancer care... Read More


New Prostate Cancer Foundation-Funded Research To Speed Up Prostate Cancer Clinical Trials Worldwide

LOS ANGELES, Calif., January 11, 2024 -- New analysis of data published by Susan Halabi, PhD, of Duke University, USA could facilitate approval of new prostate cancer treatments almost two years earlier than the current standard. The study published online January 5, 2024, in the Journal of Clinical Oncology, reviewed... Read More


The Prostate Cancer Foundation and Bayer Announce First Ever Bayer-PCF Health Equity Research Challenge Awards

LOS ANGELES, Calif., November 30, 2023 – The Prostate Cancer Foundation (PCF) and Bayer today announced three 2023 Bayer-PCF Health Equity Research Challenge Awards totaling $600,000. The awards will support novel health equity research projects with the goal of reducing racial and ethnic disparities in the diagnosis and treatment of... Read More


Pfizer and Astellas’ XTANDI® Approved by U.S. FDA in Earlier Prostate Cancer Treatment Setting

XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy* in nonmetastatic castration-sensitive prostate cancer TOKYO and NEW YORK, November 16, 2023 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Pfizer Inc. (NYSE: PFE) today... Read More


The Prostate Cancer Foundation and Bayer Announce First Ever Bayer-PCF Darolutamide Challenge Awards

LOS ANGELES, Calif., October 25, 2023 – The Prostate Cancer Foundation (PCF) and Bayer today announced two 2023 Bayer-PCF Darolutamide Challenge Awards totaling $2 million to support clinical investigations on darolutamide in prostate cancer. In 2019, the U.S. Food and Drug Administration approved Bayer’s Nubeqa® (darolutamide), an androgen receptor inhibitor... Read More


The Prostate Cancer Foundation Announces The 2023 Young Investigator Awards Totaling More Than $6 Million for Prostate Cancer Research

LOS ANGELES, Calif., October 24, 2023 – The Prostate Cancer Foundation (PCF) today announced the Class of 2023 Young Investigator Award recipients totaling $6.1 million in funding for innovative prostate cancer research. PCF Young Investigator Awards are intended to identify a cohort of future research leaders who will keep the... Read More


Washington Commanders announce month-long programming promoting early detection and celebrating survivors and those currently undergoing treatment as part of NFL’s ‘Crucial Catch’ campaign

LANDOVER, Md., October 4, 2023 – Throughout the month of October, the Washington Commanders will host events dedicated to health equity and promoting early detection best practices as part of the NFL's Annual Crucial Catch initiative. To headline the month, the team will host its Crucial Catch-themed game under the... Read More


The Prostate Cancer Foundation Challenges America To Get Healthy This September

LOS ANGELES, Calif., August 31, 2023 – September is Prostate Cancer Awareness Month and the Prostate Cancer Foundation (PCF) is challenging all Americans to Get Healthy with PCF by joining two Prostate Cancer Awareness Challenges: 108 Miles in September Run/Walk Challenge and 30 Foods in 30 Days Healthy Eating Challenge.... Read More


MLB commemorates Father’s Day in partnership with Prostate Cancer Foundation

For its 27th season, MLB and PCF has teamed up to host the Home Run Challenge. Each home run hit in all games beginning May 20 and leading up to Father’s Day (June 18) have raised money to fight prostate cancer. Fans can still visit pcf.org/homerunchallenge to pledge a donation for... Read More


ZERO Prostate Cancer Taps Breast Cancer Leader and Survivor as Next President and CEO

Washington, D.C., June 8, 2023 - After a nationwide executive search, ZERO Prostate Cancer proudly announces Courtney Bugler, CFRE, as its new President and CEO, effective August 7. Bugler, a trailblazing nonprofit leader with extensive executive experience in national health nonprofits, fundraising, and advocacy, will succeed the current President and... Read More